Ask a doctor about a prescription for DUOCLIN 10 mg/g + 50 mg/g GEL
Leaflet: Information for the user
Duoclin 10 mg/g + 50 mg/g gel
clindamycin + benzoyl peroxide anhydrous
Read the entire leaflet carefully before starting to use this medicine, as it contains important information for you.
Contents of the leaflet
Duoclin contains two active substances: clindamycin and benzoyl peroxide. Duoclin belongs to the group of medicines known as 'anti-acne preparations'.
Antibiotics are used to treat bacterial infections and are not used to treat viral infections such as the flu or the common cold.
It is essential that you follow the instructions regarding dosage, administration interval, and treatment duration indicated by your doctor.
Do not store or reuse this medicine. If you have any leftover antibiotic after finishing the treatment, return it to the pharmacy for proper disposal. Do not throw medicines down the drain or in the trash.
This medicine is used for the treatment of mild to moderate acne on your skin.
When these active substances are used together in this medicine, they help to:
Duoclin is for use in adults and adolescents aged 12 and above.
Do not use Duoclin:
Do not use this medicine if any of the above circumstances apply to you. If you are unsure, consult your doctor or pharmacist before using Duoclin.
Warnings and precautions
Consult your doctor or pharmacist before starting to use this medicine
Children
Do not use this medicine in children under 12 years of age. It is not known if it works or is safe for them.
Using Duoclin with other medicines
Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines.
Tell your doctor or pharmacist if you are using any of the following:
This is because when Duoclin is used with these products, your skin may become irritated over time.
This medicine may make some acne medicines less effective when used at the same time. This includes:
Duoclin should not be used at the same time as other medicines that contain erythromycin.
Applying Duoclin at the same time as medicines such as dapsoneand sulfacetamidemay cause a temporary change in skin or facial hair color (yellow/orange color). This effect is not permanent.
One of the components in this medicine may affect the way certain general anesthetics (called 'neuromuscular blocking agents') work.
If you are unsure about any of the above points, consult your doctor or pharmacist before using this medicine.
Pregnancy, breastfeeding, and fertility
There is limited information on the safety of using Duoclin in pregnant women.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
Your doctor will assess the benefit to you and the risk to the baby of using Duoclin during pregnancy.
It is not known if the components of this medicine are excreted in breast milk. One of the medicines contained in Duoclin is clindamycin. When clindamycin is given orally or injected, it may appear in breast milk. If you are breastfeeding, consult your doctorbefore using Duoclin.
Do not use this medicine on the breast if you are breastfeeding.
Follow the instructions for using this medicine exactly as indicated by your doctor or pharmacist. If you are unsure, consult your doctor or pharmacist.
How to apply Duoclin
Use this medicine as your doctor or pharmacist has indicated or as described in the leaflet. If you are unsure, consult your doctor or pharmacist.
If you use more Duoclin than you should
If you accidentally swallow Duoclin
In case of overdose or accidental ingestion, consult your doctor or call the Toxicology Information Service, phone 91 562 04 20, indicating the medicine and the amount ingested or used.
If you forget to use DuoclinDo not apply a double dose to make up for forgotten doses.
If you stop treatment with Duoclin
Do not use the gel for more than 12 weeks in a row without consulting your doctor. Use Clindamycin/Benzoyl peroxide for as long as your doctor recommends. Do not stop using this medicine unless your doctor advises you to do so.
It is essential that you continue using the gel as your doctor has indicated. If you stop treatment too soon, it is likely that acne will return.
If you have any questions about using this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone gets them.
Stop using Duoclin and consult your doctor immediately if you notice any of the following serious side effects – you may need urgent medical attention:
Very common side effects
(may affect more than 1 in 10 people)
At the application site:
These side effects are usually mild.
Common side effects
(may affect up to 1 in 10 people)
At the application site:
Uncommon side effects
(may affect up to 1 in 100 people)
Other side effects
Other side effects with frequency not known (frequency cannot be estimated from available data) include:
At the application site:
Reporting side effects
If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet. You can also report them directly through the Spanish Medicines Monitoring System: https://www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Store in a refrigerator (2°C – 8°C).
After the first opening of Duoclin, do not store above 25°C and discard after 2 months.
Do not use this medicine after the expiry date stated on the packaging after 'EXP'.
Medicines should not be disposed of via wastewater or household waste. Place the packaging and any unused medicines in the SIGRE collection point at the pharmacy. If you are unsure, ask your pharmacist how to dispose of the packaging and any unused medicines. This will help protect the environment.
Composition of Duoclin
Appearance of the product and package contents
Homogeneous gel, white to slightly yellowish in color, with fine visible particles.
25 g, 30 g, 50 g, or 60 g of gel in a closed aluminum tube with a white plastic cap, in a cardboard box.
Not all pack sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder
Industrial Farmacéutica Cantabria, S.A.
Ctra. Cazoña-Adarzo s/n, 39011 Santander
Spain
Manufacturer
Jadran-Galenski laboratorij d.d.
Svilno 20
51000 Rijeka
Croatia
This medicine is authorized in the Member States of the European Economic Area under the following names:
Slovenia: Klindamicin/benzoilperoksid JGL 10mg/50mg in 1 g gel
Spain: Duoclin 10mg/g + 50 mg/g gel
Italy: DUOCLIN
Portugal: DUOCLIN 10 mg/g + 50 mg/g Gel
Date of the last revision of this leaflet:06/2021
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es.